PulteGroup
PHM
112.33
-3.77
-3.25%
PulteGroup
US · PHM
#869 by market cap
Listed 1970
112.33
-3.77
-3.25%
Live - 5344 symbols - heartbeat 374s ago
· 2026-10-08 04:01
Pre-market
111.98
-0.31%
After-hours
112.33
0.00%
Overnight
111.98
-0.31%
- Market cap
- 21.06B
- P/E (TTM)i
- 11.47
- P/Bi
- 1.62
- EPSi
- 11.12
- Div yieldi
- 0.89%
- 52W posi
- 12%
Reader sentiment
Are you bullish or bearish on PHM?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.80, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.54% YoY
Margins
- Gross margin
- 26.41%
- Operating margin
- 17.21%
- Net margin
- 12.82%
Key ratios & quality
- Altman Z-Scorei
- 5.80
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 10.19B | 10.21B | 11.04B | 13.74B | 16.00B | 16.06B | 17.95B | 17.31B |
| Gross profit | 2.37B | 2.40B | 2.78B | 3.78B | 4.83B | 4.72B | 5.22B | 4.57B |
| Selling & admin expenses | 1.01B | 1.04B | 1.01B | 1.21B | 1.38B | 1.31B | 1.32B | 1.57B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.35B | 1.34B | 1.75B | 2.56B | 3.44B | 3.40B | 3.89B | 2.98B |
| Pretax profit | 1.35B | 1.34B | 1.73B | 2.51B | 3.44B | 3.45B | 4.01B | 2.91B |
| Tax | 325.52M | 322.88M | 321.86M | 563.53M | 822.24M | 846.90M | 922.62M | 692.59M |
| Net profit | 1.02B | 1.02B | 1.41B | 1.95B | 2.62B | 2.60B | 3.08B | 2.22B |
| Basic EPS | 4 | 4 | 5 | 7 | 11 | 12 | 15 | 11 |
| Diluted EPS | 3.55 | 3.66 | 5.18 | 7.43 | 11.01 | 11.72 | 14.69 | 11.12 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 3.89B | 4.40B | 4.40B | 4.61B | 3.41B | 3.98B |
| Gross profit | 1.07B | 1.20B | 1.16B | 1.14B | 822.11M | 997.52M |
| Selling & admin expenses | 393.34M | 390.45M | 400.68M | 389.46M | 380.33M | 382.97M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 671.91M | 805.45M | 761.31M | 739.91M | 440.36M | 613.14M |
| Pretax profit | 681.14M | 807.16M | 767.79M | 655.24M | 449.40M | 622.44M |
| Tax | 158.34M | 198.67M | 181.95M | 153.62M | 102.40M | 150.44M |
| Net profit | 522.80M | 608.48M | 585.83M | 501.62M | 347.00M | 472.00M |
| Basic EPS | 3 | 3 | 3 | 3 | 2 | 2 |
| Diluted EPS | 2.57 | 3.03 | 2.96 | 2.56 | 1.79 | 2.48 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 9.58B | 10.14B | 11.64B | 12.71B | 14.10B | 15.37B | 16.58B | 17.37B |
| Cash & ST investments | 1.57B | 1.73B | 3.15B | 2.73B | 1.73B | 2.32B | 2.24B | 2.59B |
| Inventory | 7.25B | 7.68B | 7.72B | 9.05B | 11.33B | 11.80B | 12.67B | 12.91B |
| Total assets | 10.17B | 10.72B | 12.21B | 13.35B | 14.80B | 16.09B | 17.36B | 18.05B |
| Total current liabilities | 670.75M | 778.83M | 1.01B | 1.62B | 1.60B | 1.56B | 1.50B | 1.37B |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 3.38B | 3.09B | 3.16B | 2.66B | 2.63B | 2.46B | 2.15B | 2.16B |
| Total liabilities | 5,355,194,000.00 | 5,257,417,000.00 | 5,635,509,000.00 | 5,863,116,000.00 | 5,882,417,000.00 | 5,703,793,000.00 | 5,241,799,000.00 | 5,062,981,000.00 |
| Total equity | 4.82B | 5.46B | 6.57B | 7.49B | 8.91B | 10.38B | 12.12B | 12.99B |
| Retained earnings | 1.61B | 2.22B | 3.31B | 4.20B | 5.58B | 7.01B | 8.69B | 9.49B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 14.88B | 15.06B | 15.32B | 17.37B | 15.65B | 15.64B |
| Cash & ST investments | 1.88B | 1.82B | 1.94B | 2.59B | 2.32B | 1.89B |
| Inventory | 12.96B | 13.22B | 13.35B | 12.91B | 13.30B | 13.72B |
| Total assets | 17.34B | 17.59B | 17.85B | 18.05B | 18.20B | 18.26B |
| Total current liabilities | 2.52B | 2.43B | 2.51B | 1.37B | 2.51B | 2.49B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 2.05B | 2.12B | 2.03B | 2.16B | 2.28B | 2.30B |
| Total liabilities | 5,035,574,000.00 | 5,012,869,000.00 | 5,024,942,000.00 | 5,062,981,000.00 | 5,241,828,000.00 | 5,249,459,000.00 |
| Total equity | 12.30B | 12.57B | 12.83B | 12.99B | 12.95B | 13.01B |
| Retained earnings | 8.85B | 9.11B | 9.35B | 9.49B | 9.44B | 9.49B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.45B | 1.08B | 1.78B | 1.00B | 668.47M | 2.20B | 1.68B | 1.87B |
| Depreciation & amortization | 49.43M | 54.00M | 66.08M | 69.95M | 70.92M | 80.82M | 89.16M | 112.51M |
| Free cash flow | 1.39B | 1.02B | 1.73B | 931.24M | 555.81M | 2.10B | 1.56B | 1.75B |
| Dividends paid | -104.02M | -122.35M | -130.18M | -147.83M | -144.12M | -142.46M | -167.71M | -176.68M |
| Stock buybacks / issuance | -302.48M | -285.78M | -185.53M | -908.15M | -1.09B | -1.01B | -1.22B | -1.22B |
| Ending cash balance | 1.13B | 1.25B | 2.63B | 1.83B | 1.09B | 1.85B | 1.65B | 2.01B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 134.23M | 287.51M | 678.39M | 771.13M | 159.75M | 17.05M |
| Depreciation & amortization | 24.67M | 25.05M | 25.84M | 36.96M | 24.54M | 25.40M |
| Free cash flow | 104.62M | 252.97M | 651.13M | 739.81M | 134.36M | -12.85M |
| Dividends paid | -45.82M | -44.26M | -43.58M | -43.03M | -52.04M | -49.79M |
| Stock buybacks / issuance | -323.42M | -300.34M | -300.54M | -300.03M | -345.00M | -374.23M |
| Ending cash balance | 1.28B | 1.27B | 1.48B | 2.01B | 1.84B | 1.38B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 22.53 | 19.59 | 23.19 | 27.45 | 31.71 | 26.87 | 27.40 | 17.67 |
| ROA %i | 10.18 | 9.64 | 12.17 | 15.10 | 18.48 | 16.79 | 18.43 | 12.53 |
| ROIC %i | 12.73 | 11.81 | 15.08 | 19.23 | 23.77 | 20.73 | 22.24 | 14.74 |
| 5-year avg ROE %i | 13.10 | 15.03 | 17.61 | 20.56 | 24.89 | 25.76 | 27.33 | 26.22 |
| EBIT margin %i | 13.23 | 13.12 | 15.70 | 18.03 | 21.20 | 21.48 | 22.32 | 16.82 |
| FCF / sales %i | 13.65 | 9.98 | 15.64 | 6.69 | 3.42 | 13.10 | 8.70 | 10.10 |
| Current ratioi | 14.29 | 13.02 | 11.50 | 7.85 | 8.82 | 9.87 | 11.08 | 12.64 |
| Quick ratioi | 2.86 | 2.54 | 3.38 | 1.86 | 1.25 | 1.64 | 1.67 | 2.08 |
| Debt / assetsi | 33.19 | 29.70 | 26.67 | 20.58 | 18.40 | 15.87 | 12.98 | 12.73 |
| LT debt / equityi | 70.08 | 58.32 | 49.55 | 36.69 | 30.54 | 24.59 | 18.60 | 17.69 |
| Interest coveragei | 2,181.49 | 2,294.79 | 407.94 | 5,000.69 | 12,112.12 | 7,355.51 | 8,364.00 | 4,813.10 |
| Revenue CAGR (3Y) %i | 19.42 | 9.98 | 8.76 | 10.47 | 16.15 | 13.32 | 9.32 | 2.66 |
| Net income CAGR (3Y) %i | 27.41 | 19.04 | 46.52 | 23.95 | 37.05 | 22.76 | 16.57 | -5.36 |
| FCF CAGR (3Y) %i | -- | 227.51 | 39.85 | -12.48 | -18.27 | 6.83 | 18.82 | 46.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 25.52 | 23.05 | 21.57 | 17.67 | 16.18 | 14.90 |
| ROA %i | 17.40 | 16.07 | 15.11 | 12.53 | 11.50 | 10.64 |
| ROIC %i | 21.03 | 19.65 | 18.19 | 14.74 | 13.57 | 12.46 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 21.35 | 20.22 | 19.52 | 16.82 | 15.93 | 15.21 |
| FCF / sales %i | 8.11 | 7.45 | 8.81 | 10.10 | 10.57 | 9.22 |
| Current ratioi | 5.90 | 6.20 | 6.11 | 12.64 | 6.24 | 6.28 |
| Quick ratioi | 0.75 | 0.75 | 0.77 | 2.08 | 0.92 | 0.76 |
| Debt / assetsi | 11.84 | 12.06 | 11.36 | 12.73 | 12.51 | 12.58 |
| LT debt / equityi | 16.69 | 16.87 | 15.81 | 17.69 | 17.57 | 17.66 |
| Interest coveragei | 7,777.73 | 6,947.05 | 6,087.39 | 4,813.10 | 4,174.80 | 4,111.15 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Homebuilding Florida is the largest reported line at 26.31% of revenue, across 8 reported segments.
- No single line clears half of revenue; Homebuilding West is next at 19.59%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Homebuilding Florida26.31%
Homebuilding West19.59%
Homebuilding Southeast17.49%
Homebuilding Midwest15.97%
Homebuilding Texas10.31%
Homebuilding Northeast5.88%
Financial services2.43%
Other homebuilding2.02%
Quote time 2026-10-08 04:01:04 · For reference only, not investment advice and not tailored to your situation.